• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHEK2 的可变剪接与 NF2 缺失共同促进脑膜瘤的染色体不稳定性。

Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma.

机构信息

Department of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

出版信息

Neoplasia. 2012 Jan;14(1):20-8. doi: 10.1593/neo.111574.

DOI:10.1593/neo.111574
PMID:22355270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3281938/
Abstract

Mutations of the NF2 gene on chromosome 22q are thought to initiate tumorigenesis in nearly 50% of meningiomas, and 22q deletion is the earliest and most frequent large-scale chromosomal abnormality observed in these tumors. In aggressive meningiomas, 22q deletions are generally accompanied by the presence of large-scale segmental abnormalities involving other chromosomes, but the reasons for this association are unknown. We find that large-scale chromosomal alterations accumulate during meningioma progression primarily in tumors harboring 22q deletions, suggesting 22q-associated chromosomal instability. Here we show frequent codeletion of the DNA repair and tumor suppressor gene, CHEK2, in combination with NF2 on chromosome 22q in a majority of aggressive meningiomas. In addition, tumor-specific splicing of CHEK2 in meningioma leads to decreased functional Chk2 protein expression. We show that enforced Chk2 knockdown in meningioma cells decreases DNA repair. Furthermore, Chk2 depletion increases centrosome amplification, thereby promoting chromosomal instability. Taken together, these data indicate that alternative splicing and frequent codeletion of CHEK2 and NF2 contribute to the genomic instability and associated development of aggressive biologic behavior in meningiomas.

摘要

NF2 基因突变被认为是近 50%脑膜瘤发生肿瘤形成的原因,而 22q 缺失是这些肿瘤中最早和最常见的大规模染色体异常。在侵袭性脑膜瘤中,22q 缺失通常伴随着涉及其他染色体的大规模节段性异常的存在,但这种关联的原因尚不清楚。我们发现,脑膜瘤进展过程中大规模染色体改变主要发生在携带 22q 缺失的肿瘤中,这表明 22q 相关的染色体不稳定性。在这里,我们显示在大多数侵袭性脑膜瘤中,DNA 修复和肿瘤抑制基因 CHEK2 与 22q 上的 NF2 频繁共缺失。此外,脑膜瘤中 CHEK2 的肿瘤特异性剪接导致功能性 Chk2 蛋白表达减少。我们表明,在脑膜瘤细胞中强制敲低 Chk2 会降低 DNA 修复。此外,Chk2 耗竭会增加中心体扩增,从而促进染色体不稳定。总之,这些数据表明 CHEK2 和 NF2 的选择性剪接和频繁共缺失导致脑膜瘤中基因组不稳定性和相关侵袭性生物学行为的发展。

相似文献

1
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma.CHEK2 的可变剪接与 NF2 缺失共同促进脑膜瘤的染色体不稳定性。
Neoplasia. 2012 Jan;14(1):20-8. doi: 10.1593/neo.111574.
2
NF2 mutations in secretory and other rare variants of meningiomas.脑膜瘤分泌型及其他罕见变异型中的NF2突变
Brain Pathol. 2006 Jan;16(1):15-9. doi: 10.1111/j.1750-3639.2006.tb00557.x.
3
Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.散发性脑膜瘤22号染色体长臂上的宏观突变及神经纤维瘤病2型(NF2)基因座内的微观突变的综合遗传和表观遗传分析。
BMC Genomics. 2007 Jan 12;8:16. doi: 10.1186/1471-2164-8-16.
4
Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.22号染色体q区与2型神经纤维瘤病基因在中枢神经系统肿瘤中的联合分子遗传学研究。
Neurosurgery. 1995 Oct;37(4):764-73. doi: 10.1227/00006123-199510000-00022.
5
Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.散发性脑膜瘤中2型神经纤维瘤病(NF2)基因突变的筛查。
Hum Genet. 1996 May;97(5):632-7. doi: 10.1007/BF02281874.
6
BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.在一个新的最小缺失区域内显示22号染色体长臂杂合性缺失的脑膜瘤中,BCR表达降低。
Cancer Genet Cytogenet. 2008 May;183(1):14-20. doi: 10.1016/j.cancergencyto.2008.01.020.
7
First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.对2型神经纤维瘤病相关的I级和II级脑膜瘤体细胞突变负担的初步见解:一项对两例临床表现差异极大的颅脑膜瘤的病例报告及综合基因组研究。
BMC Cancer. 2017 Feb 13;17(1):127. doi: 10.1186/s12885-017-3127-6.
8
Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.在散发性脑膜瘤中,默林蛋白表达缺失与22号染色体长臂杂合性缺失紧密相关。
Cancer Res. 1999 Dec 1;59(23):5995-8.
9
Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.散发性脑膜瘤中2型神经纤维瘤病基因的体细胞突变。
Hum Genet. 1995 Mar;95(3):347-51. doi: 10.1007/BF00225206.
10
Deletions on chromosome 22 in sporadic meningioma.散发性脑膜瘤中22号染色体的缺失
Genes Chromosomes Cancer. 1994 Jun;10(2):122-30. doi: 10.1002/gcc.2870100207.

引用本文的文献

1
Multi-omics and Mendelian randomization study explores potential therapeutic targets for meningiomas.多组学与孟德尔随机化研究探索脑膜瘤的潜在治疗靶点。
Discov Oncol. 2025 Aug 2;16(1):1457. doi: 10.1007/s12672-025-03318-0.
2
Exploring the genetic correlation and causal relationships between breast cancer and meningioma using bidirectional Mendelian randomization.使用双向孟德尔随机化方法探索乳腺癌与脑膜瘤之间的遗传相关性和因果关系。
Sci Rep. 2025 Feb 4;15(1):4271. doi: 10.1038/s41598-025-88829-0.
3
RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups.RNA剪接作为脑膜瘤DNA甲基化组的生物标志物和表型驱动因素。
Neuro Oncol. 2024 Dec 5;26(12):2222-2236. doi: 10.1093/neuonc/noae150.
4
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.脑膜瘤:脑膜瘤国际联合会关于临床医生、研究人员和患者的科学进展和治疗模式的共识综述。
Neuro Oncol. 2024 Oct 3;26(10):1742-1780. doi: 10.1093/neuonc/noae082.
5
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.剪接调节剂可损害 DNA 损伤反应并诱导黏连蛋白突变型 MDS 和 AML 细胞死亡。
Sci Transl Med. 2024 Jan 3;16(728):eade2774. doi: 10.1126/scitranslmed.ade2774.
6
Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas.中枢神经系统肿瘤的家畜模型:聚焦于脑膜瘤
Life (Basel). 2023 Nov 30;13(12):2284. doi: 10.3390/life13122284.
7
Alterations in Pediatric Malignancy: A Single-Institution Experience.小儿恶性肿瘤的变化:单机构经验
Cancers (Basel). 2023 Mar 8;15(6):1649. doi: 10.3390/cancers15061649.
8
Brain Invasion and Trends in Molecular Research on Meningioma.脑膜瘤的脑侵袭及分子研究趋势
Brain Tumor Res Treat. 2023 Jan;11(1):47-58. doi: 10.14791/btrt.2022.0044.
9
Two unrelated cases with biallelic CHEK2 variants:a novel condition with constitutional chromosomal instability?两个具有双等位 CHEK2 变异的无关病例:一种具有遗传性染色体不稳定性的新型疾病?
Eur J Hum Genet. 2023 Apr;31(4):474-478. doi: 10.1038/s41431-022-01270-z. Epub 2022 Dec 19.
10
Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.儿科癌症中的选择性 RNA 剪接缺陷:肿瘤发生中的新见解和潜在的治疗弱点。
Ann Oncol. 2022 Jun;33(6):578-592. doi: 10.1016/j.annonc.2022.03.011. Epub 2022 Mar 23.

本文引用的文献

1
Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status.基因组分析揭示了依赖于潜在 NF2 状态的脑膜瘤恶性进展的替代遗传途径。
Clin Cancer Res. 2010 Aug 15;16(16):4155-64. doi: 10.1158/1078-0432.CCR-10-0891. Epub 2010 Aug 3.
2
SNAI2/Slug promotes growth and invasion in human gliomas.SNAI2/ slug 促进人脑胶质瘤的生长和侵袭。
BMC Cancer. 2010 Jun 17;10:301. doi: 10.1186/1471-2407-10-301.
3
The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells.chk2-brCA1 肿瘤抑制途径确保人类体细胞的染色体稳定性。
Nat Cell Biol. 2010 May;12(5):492-9. doi: 10.1038/ncb2051. Epub 2010 Apr 4.
4
A mechanism linking extra centrosomes to chromosomal instability.一种将额外中心体与染色体不稳定性相联系的机制。
Nature. 2009 Jul 9;460(7252):278-82. doi: 10.1038/nature08136. Epub 2009 Jun 7.
5
Cdc25A serine 123 phosphorylation couples centrosome duplication with DNA replication and regulates tumorigenesis.细胞周期蛋白依赖性激酶25A(Cdc25A)丝氨酸123位点的磷酸化将中心体复制与DNA复制联系起来,并调节肿瘤发生。
Mol Cell Biol. 2008 Dec;28(24):7442-50. doi: 10.1128/MCB.00138-08. Epub 2008 Oct 20.
6
Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.中心体周期失调与癌症中染色体不稳定性的起源
Adv Exp Med Biol. 2005;570:393-421. doi: 10.1007/1-4020-3764-3_14.
7
Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage.Chk2抑制与DNA复制相关的DNA损伤的致癌潜能。
Mol Cell. 2008 Jul 11;31(1):21-32. doi: 10.1016/j.molcel.2008.04.028.
8
The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.CHK1和CHK2在维持基因组稳定性中的多重检查点功能。
Front Biosci. 2008 May 1;13:5016-29. doi: 10.2741/3060.
9
P53, cyclin-dependent kinase and abnormal amplification of centrosomes.P53、细胞周期蛋白依赖性激酶与中心体异常扩增。
Biochim Biophys Acta. 2008 Sep;1786(1):15-23. doi: 10.1016/j.bbcan.2008.04.002. Epub 2008 Apr 22.
10
CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?CHK2激酶:癌症易感性与癌症治疗——同一枚硬币的两面?
Nat Rev Cancer. 2007 Dec;7(12):925-36. doi: 10.1038/nrc2251.